Seyed Mohammadreza Bolandi 个人学术档案

20212022202320245 8 11 20

开放获取的出版物数量

1 篇文章

0 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

Mohammad-Ali AssarehzadeganImmunology Department, School of Medicine, Iran University of Medical Sciences (IUMS)在 iums.ac.ir 的电子邮件经过验证
zohreh abdolmalekiprofessor of pharmacology, Islamic Azad University,Karaj branch, Karaj, Iran在 kiau.ac.ir 的电子邮件经过验证
Peyman BeigiHematology department, Faculty of Medicine, University of Tarbiat Modares在 modares.ac.ir 的电子邮件经过验证
Anna M. EiringTexas Tech University Health Sciences Center El Paso在 ttuhsc.edu 的电子邮件经过验证
Jamshid S KhorashadHonorary Senior Lecturer at Imperial College London在 imperial.ac.uk 的电子邮件经过验证

Seyed Mohammadreza Bolandi

其他姓名Seyedmohammmadreza Bolandi

Department of Pharmacology, Karaj Branch, Islamic Azad University, Karaj, Iran.

在 ulaval.ca 的电子邮件经过验证


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
A role for the bone marrow microenvironment in drug resistance of acute myeloid leukemia SM Bolandi, M Pakjoo, P Beigi, M Kiani, A Allahgholipour, N Goudarzi, ... Cells 10 (11), 2833, 2021	22	2021
Rhabdomyosarcoma: current therapy, challenges, and future approaches to treatment strategies A Zarrabi, D Perrin, M Kavoosi, M Sommer, S Sezen, P Mehrbod, ... Cancers 15 (21), 5269, 2023	9	2023
Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivity SM Bolandi, Z Abdolmaleki, MA Assarehzadegan Inflammopharmacology 29, 683-694, 2021	7	2021
Anti-angiogenic properties of bevacizumab improve respiratory system inflammation in ovalbumin-induced rat model of asthma SM Bolandi, Z Abdolmaleki, MA Assarehzadegan Inflammation 44 (6), 2463-2475, 2021	6	2021

系统目前无法执行此操作，请稍后再试。

文章 1–4

每年引用数